Overview

Low Dose of Diltiazem for Rate Control of Atrial Fibrillation

Status:
Unknown status
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
This study is to show the efficacy and safety of low dose diltiazem for the treatment of atrial fibrillation with rapid ventricular response in emergency room. We will compare the standard dose of diltiazem(0.25mg/kg) with low dose diltiazem(0.1mg/kg)in atrial fibrillation with rapid ventricular response in ED.
Phase:
Phase 4
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Diltiazem